EP 1824846 A2 20070829 - NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
Title (en)
NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
Title (de)
NEUE VERBINDUNGEN ZUR BEHANDLUNG NEUROLOGISCHER ERKRANKUNGEN
Title (fr)
NOUVEAUX COMPOSES POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES
Publication
Application
Priority
- EP 2005012765 W 20051130
- US 216904 A 20041202
- US 68413705 P 20050524
- US 51671703 P 20031103
- US 97667704 A 20041029
Abstract (en)
[origin: WO2006058720A2] The present invention relates to novel inhibitors of prolyl endopeptidase of formula (I): W-KCONH-X-CON-Y-CO-Z, wherein K, W; X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease. Down Syndrome, Parkinson disease and Chorea Huntington.
IPC 8 full level
C07D 417/06 (2006.01); A61K 31/425 (2006.01); A61P 25/28 (2006.01); C07D 403/06 (2006.01)
CPC (source: EP)
A61P 25/28 (2017.12); C07D 417/06 (2013.01); C07D 417/14 (2013.01)
Citation (search report)
See references of WO 2006058720A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006058720 A2 20060608; WO 2006058720 A3 20060727; EP 1824846 A2 20070829
DOCDB simple family (application)
EP 2005012765 W 20051130; EP 05826439 A 20051130